biomarker discovery
Lupus Research Alliance Launches Landmark Study to Speed Personalized Drug Development
Investigators aim to enroll 3,500 patients into the prospective, observational study, which is supported by multiple drugmakers.
FDA Advisory Committee in Close Vote Backs Approval of Sarepta Therapeutics' DMD Gene Therapy
After weighing FDA and company experts' divergent interpretations of the evidence, the expert panel decided to recommend approval, eight to six.
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
FDA Has Concerns About Surrogate Endpoint Data Sarepta Therapeutics Submitted for DMD Gene Therapy
Reviewers from the agency also flagged safety concerns about SRP-9001 ahead of an advisory committee meeting later this week.
Caris Life Sciences, Flare Therapeutics Collaborate to Advance Oncology Programs
Flare will leverage Caris' capabilities in sequencing, data analytics, and biomarker-driven patient selection to advance five of its pipeline programs.
Sep 29, 2022